ClinDatrix client AiViva Biopharma launches “A Phase 2, Multicenter, Randomized, Active-controlled Trial of the Safety and Efficacy of AIV007 by Periocular Injection in Patients with Neovascular Age-Related Macular Degeneration (nAMD).” Up to fifteen sites are anticipated.
ClinDatrix Client AiViva Biopharma Launches a New StudyRead More